Status:
UNKNOWN
Coagulation Parameters During Pregnancy in Amniotic Fluid
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Pregnancy
Eligibility:
FEMALE
18-40 years
Brief Summary
Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activator...
Detailed Description
Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activator...
Eligibility Criteria
Inclusion
- Women undergoing amniocentesis during 15-35 weeks of gestation.
Exclusion
- A history of venous thromboembolism
- Systemic disease i.e.; diabetes, hypertension, hypo or hyper-thyroidism,
- Anticoagulant treatment
- Abnormal embryo
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00458666
Start Date
June 1 2006
Last Update
April 11 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Obstetrics and Gynecology, Rambam-Health Care Campus
Haifa, Israel